A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy

Annals of Oncology

Volumn 10, Issue 3, 1999, Pages 295-303

  Sculier, J P ^a   Paesmans, M ^a   Lafitte, J J ^a   Baumohl J ^a   Thiriaux, J ^a   Van Cutsem, O ^a   Recloux, P ^a   Bureau, G ^a   Berchier, M C ^a   Zacharias, C ^a   Mommen, P ^a   Bosschaerts, T ^a   Berghmans, T ^a   Van Houtte, P ^a   Ninane, V ^a   Klastersky, J ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

Chest irradiation; Induction chemotherapy; Locoregional disease; Non small cell lung cancer; Randomised trial

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; IFOSFAMIDE; MITOMYCIN C;

ADULT; AGED; ALOPECIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG INDUCED DISEASE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NAUSEA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IFOSFAMIDE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MITOMYCINS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032915371     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008319506107     Document Type: Article

References (44)

1. The Non-Small-Cell Lung Cancer Expert Panel. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. J Clin Oncol 1997; 15: 2996-3018.
2. Mattson K, Holsti LR, Holsti P et al. Inoperable non-small-cell lung cancer: Radiation with or without chemotherapy. Eur J Cancer Clin Oncol 1988; 24: 477-82.
3. Dillman RO, Seagren SL, Propert KJ et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 1990; 323: 940-5.
4. Dillman RO, Herndon J, Seagren SL et al. Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. J Natl Cancer Inst 1996; 88: 1210-5.
5. Le Chevalier T, Arriagada R, Quoix E et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991; 83: 417-23.
6. Le Chevalier T, Arriagada R, Tarayre M et al. Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma, J Natl Cancer Inst 1992; 84: 58.
7. Wolf M, Hans K, Becker H et al. Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small-cell lung cancer. Semin Oncol 1994; 21 (Suppl 4): 42-7.
8. Sause WT, Scott C, Taylor S et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer. J Natl Cancer Inst 1995; 87: 198-205.
9. Brodin O, Nou E, Mercke C et al. for the Swedish Lung Cancer Study Group. Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung. Eur J Cancer 1996; 32A: 1893-900.
10. Morton RF, Jett JR, McGinnis WL et al. Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small-cell lung cancer. A randomized, phase III trial. Ann Intern Med 1991; 115: 681-6.
11. Gregor A, Macbeth FR, Paul J et al. Radical radiotherapy and chemotherapy in localized inoperable non-small-cell lung cancer: A randomized trial. J Natl Cancer Inst 1993; 85: 997-9.
12. Crino L, Latini P, Meacci M et al. Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer. Ann Oncol 1993; 4: 847-51.
13. Planting A, Helle P, Drings P et al. A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high-dose radiotherapy only in locally advanced non-small-cell lung cancer. An EORTC Lung Cancer Cooperative Group trial. Ann Oncol 1996; 7: 139-44.
14. Non-small-Cell Lung Cancer Collaborative Group. Chemotherapy in non-small-cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995; 311: 899-909.
15. Kaasa S, Thorud E, Host H et al. A randomized study evaluating radiotherapy versus chemotherapy in patients with inoperable non-small-cell lung cancer. Radiother Oncol 1988; 11: 7-13.
16. Johnson DH, Einhorn LH, Bartolucci A et al. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small-cell lung cancer. Ann Intern Med 1990; 113: 33-8.
17. Kubota K, Furuse K, Kawahara M et al. Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer. J Clin Oncol 1994; 12: 1547-52.
18. Marino P, Preatoni A, Cantoni A. Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb non-small-cell lung cancer. Cancer 1995; 76: 593-601.
19. Pritchard RS, Anthony SP. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. Ann Intern Med 1996; 125: 723-9.
20. Durrant KR, Ellis F, Black JM et al. Comparison of treatment policies in inoperable bronchial carcinoma. Lancet 1971; i: 715-9.
21. Roswit B, Patno ME, Rapp R et al. The survival of patients with inoperable lung cancer: A large scale randomized study of radiation therapy versus placebo. Radiology 1968; 90: 688-97.
22. Wolf J, Patno ME, Roswitt B, D'Esopo N. Controlled study of survival of patients with clinically inoperable lung cancer treated with radiation therapy. Am J Med 1966; 40: 360-7.
23. Damstrup L, Skovgaard Poulsen H. Review of the curative role of radiotherapy in the treatment of non-small-cell lung cancer. Lung Cancer 1994; 11: 153-78.
24. Kaskowitz L, Graham MV, Emami B et al. Radiation therapy alone for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 1993; 27: 517-23.
25. Slotman BJ, Njo KH, Karim ABMF. Curative radiotherapy for technically operable stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 1994; 29: 33-7.
26. Gauden S, Ramsay J, Tripcony L. The curative treatment by radiotherapy alone of stage I non-small-cell carcinoma of the lung. Chest 1995; 108: 1278-82.
27. Graham PH, Gebski VJ, Langlands AO. Radical radiotherapy for early non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 1995; 31: 261-6.
28. Burkes RL, Ginsberg RJ, Shepherd FA et al. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: Results of the Toronto phase II trial. J Clin Oncol 1992; 10: 580-6.
29. Weiden PL, Piantadosi S for the Lung Cancer Study Group. Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung cancer: A phase II study of the Lung Cancer Study Group. J Natl Cancer Inst 1991; 83: 266-72.
30. Strauss GM, Herndon JE, Sherman DD et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: Report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 1992; 10: 1237-44.
31. Pujol JL, Hayot M, Rouanet P et al. Long-term results of neo-adjuvant ifosfamide, cisplatin, and etoposide combination in locally advanced non-small-cell lung cancer. Chest 1994; 106: 1451-5.
32. Weitberg AB, Yashar J, Glicksman AS et al. Combined modality therapy for stage IIIA non-small-cell carcinoma of the lung. Eur J Cancer 1993; 29A: 511-5.
33. Martini N, Kris MG, Flehinger BJ et al. Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients. Ann Thorac Surg 1993; 55: 1365-74.
34. Rusch VW, Albain KS, Crowley JJ et al. and the Southwest Oncology Group. Neoadjuvant therapy: A noveland effective treatment for stage IIIb non-small-cell lung cancer. Ann Thorac Surg 1994; 58: 290-5.
35. Rice TW, Adelstein DJ, Koka A et al. Accelerated induction therapy and resection for poor prognosis stage III non-small-cell lung cancer. Ann Thorac Surg 1995; 60: 586-92.
36. Albain KS, Rusch VW, Crowley JJ et al. Concurrent cisplatin/ etoposide plus chest radiotherapy followed by surgery for stage IIIA(N2) and IIIB non-small-cell lung cancer: Mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995; 13: 1880-92.
37. Borges M, Sculier JP, Paesmans M et al. Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small-cell lung cancer (NSCLC). Lung Cancer 1996; 16: 21-33.
38. Paesmans M, Sculier JP, Libert P et al. for the European Lung Cancer Working Party. Prognostic factors for survival in advanced non-small-cell lung cancer: Univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1052 patients. J Clin Oncol 1995; 13: 1221-30.
39. Sculier JP, Paesmans M, Libert P et al. for the European Lung Cancer Working Party. Eur J Cancer 1994; 30A: 1342-7.
40. Cullen MH, Joshi R, Chetiyawardana AD, Woodroffe CM. Mitomycin, ifosfamide and cisplatin in non-small-cell lung cancer: Treatment good enough to compare. Br J Cancer 1988; 58: 359-61.
41. Cullen MH, Billingham LJ, Woodroffe CM et al. Mitomycin, ifosfamide and cisplatin (MIC) in non-small-cell lung cancer (NSCLC): 1. Results of a randomised trial in patients with localised, inoperable disease. Lung Cancer 1997; 18 (Suppl 1): 5.
42. Donnadieu N, Paesmans M, Sculier JP. Chemotherapy of non-small-cell lung cancer according to disease extent: A meta-analysis of the literature. Lung Cancer 1991; 7: 243-52.
43. Sculier JP, Paesmans M, Thiriaux J et al. and the European Lung Cancer Working Party. A phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. J Clin Oncol 1998; 16: 1388-96.
44. Crino L, Clerici M, Figoli F et al. Chemotherapy of advanced non-small-cell lung cancer: A comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (GOIRC). Ann Oncol 1995; 6: 347-53.